OncoTrap, Inc.

Biotechnology company · Chapel Hill, North Carolina, United States

OncoTrap, Inc. is a biotechnology company headquartered in Chapel Hill, North Carolina, United States. Its earliest recorded incorporation is in 2016. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $1.1 million in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $5 million sold in a notice filed in 2017.

Profile compiled from public records. Is this your company? Request a correction or update

OncoTrap at a glance

Typebiotechnology company
HeadquartersChapel Hill, North Carolina, United States
Earliest incorporation on record2016
Employees (self-reported, 2023)5
SEC CIK1717561

What does OncoTrap do?

US government research funding

3 SBIR/STTR small-business research awards from US health agencies, $1.1 million in total (2022 to 2023). NIH funding came from the National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Cancer Institute.

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $5 million sold (2017).

Frequently asked questions about OncoTrap

Where is OncoTrap headquartered?

OncoTrap, Inc. is headquartered in Chapel Hill, North Carolina, United States.

What does OncoTrap do?

OncoTrap, Inc. is a biotechnology company.

When was OncoTrap founded?

The earliest incorporation on record for OncoTrap, Inc. is in 2016, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences